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339 Cystic ﬁbrosis-related diabetes (CFRD) in the Czech Republic
S. Kolouskova1, D. Zemkova1, V. Skalicka1, J. Bartosova1, V. Vavrova1. 1CF
Centre, Charles Univ. 2nd Med. School and Univ. Hospital Motol, Prague, Czech
Republic
Data from multicentric studies demonstrate worsening of nutritional status, lung
function and shortening of lifespan in CFRD patients. A cross sectional study of
CF patients from Czech Republic (n = 471, 64 CFRD, 15 impaired glucose tolerance
IGT) corresponds with data from literature. After 23 years of age the nutritional
status and lung functions are signiﬁcantly worse in the CFRD/IGT group (BMI
−0.9±SD vs −0.2±1.2 SD, p = 0.005; FEV1 51±22.9% pv vs 66.9±24.2% pv,
p< 0.01). We compared these results with prospective pair study of 29 insulinopenic
patients diagnosed by regular screening (oGTT) in the years 1997–2002. Controls
were sex/age matched to cases. In this study we did not prove signiﬁcant difference
between the group treated by insulin and control group during the follow up period
(range 5−9.6). At the last examination the median age of the patients was 23.4
years, FEV1 in cases 62.3±25.4 vs 60.9±24.4 in controls. During the study in 4
controls insulinopenia was detected. In treated cases 4 females died, in controls 3
females and 3 males were deceased (one with insulinopenia). Cross sectional data
in patients older than 23 years show adverse inﬂuence of CFRD on nutritional status
and pulmonary function. Our prospective pair study of early detected and treated
children did not prove this adverse effect at least after 5 years of treatment. We
suppose that the worsening could be caused not only by long lasting hyperglycaemia,
but especially by insulinopenia, insufﬁcient management of CFRD and/or non-
compliance.
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We evaluated impaired glucose tolerance and its variations during a 10 years period
in 2 groups of CF patients:13 adults (10 F, mean age 30±3, range 25−36 yrs); 21
adolescents (8 F, mean age 20±3, range 14−24 yrs). At baseline (time A) and 10
years after (time B) we assessed the intravenous glucose tolerance test (IVGTT),
body mass index (BMI, %) and forced expiratory volume at ﬁrst sec (FEV1, %
pred.). At the time B the patients underwent oral glucose tolerance test (OGTT).
Based on the ﬁrst phase insulin response (FPIR) during the IVGTT, the patients
were classiﬁed as normal (FPIR between 3−97º centile) and with insulin deﬁciency
(FPIR below 3º centile). The OGTT was classiﬁed according to the CF international
criteria. The FPIR values (mean± SD) were 100± 69 and 67±48 in adults and
68±43 and 61±43 in adolescents at time A and time B, respectively. No signiﬁcant
relationships were found between FPIR changes and age, BMI, FEV1 changes in
10 years period. In the adult group 54% and 69% showed insulin deﬁciency at time
A and time B, respectively. In adults with reduced insulin levels, OGTT revealed 2
diabetes.
In adolescent group 67% and 76% showed insulin deﬁciency at time A and time
B, respectively. In young patients with reduced insulin levels, OGTT revealed 2
diabetes.
Our results conﬁrm that insulin deﬁciency is very common in both adult and
adolescent CF patients. In addition, our study did not ﬁnd any signiﬁcant changes
in insulin levels through the time and no signiﬁcant relationships between insulin
secretion, nutritional status and pulmonary function.
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Background: In this study we investigated the prevalence of cystic ﬁbrosis-
related diabetes (CFRD) in a Dutch CF centre for children and adults. Further
the relationship between CFRD and several clinical parameters was studied.
Methods: All exocrine pancreatic insufﬁcient CF patients older than 10 years
underwent their yearly oral glucose tolerance test. All patients were classiﬁed as
having either normal glucose tolerance (NGT), impaired glucose tolerance (IGT) or
CFRD. Associations with the following parameters were studied: age, gender, BMI,
mutations, FEV1 % predicted, FVC % predicted, chronic pseudomonas infections,
Burkholderia cepacia infections, liver disease, ABPA, and hospitalization.
Results: In the total study population prevalence of IGT and CFRD is respectively
16% and 31%. After exclusion of all pancreas sufﬁcient patients, prevalence
of CFRD rises up to 40% and in patients over 40 years even up to 52%. In
comparison with patients with a NGT, CFRD patients are older (p = 0.022), have
worse pulmonary functions (p< 0.001) and stay longer in the hospital (p = 0.002).
There is a tendency in CFRD patients towards more chronic pseudomonas infections
and more DF508 mutations. Women develop CFRD on a signiﬁcantly younger age
than men (respectively 19.5 and 27.5 years, p = 0.008), though there is no difference
in total prevalence.
Conclusion: Prevalence of CFRD is increasing in CF populations and is strongly
associated with worse clinical status of the patients. Women develop CFRD on a
younger age. This knowledge is important for understanding the pathophysiology
and clinical importance of CFRD.
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Introduction: The UK CF Trust Diabetes working group 2004 highlighted a need
for an annual review of CFRD and that monitoring and treatment is vital in
preventing decline in weight and lung function. In 2006, the CF service based
in Ninewells Hospital, Dundee had 40 adult patients of which 15 had developed
CFRD. These patients attended a diabetes and CF clinic several times per annum.
It was hypothesised that treatment and outcome measures could be improved if a
joint service was provided. Patient views were sought on this and a new model of
care adopted.
Method: The 15 patients with CFRD completed a questionnaire based on their
experiences of attending both a diabetes and CF clinic.
Results: 14 questionnaires were completed and the main points extrapolated were:
1. 13/14 of patients had attended a diabetes clinic within the last year in a variety
of locations within Tayside. Missed appointments were due to time pressures
with other clinic/work/social commitments.
2. Patients perceived that the diabetes nurse and review of insulin treatment was
the most helpful in clinic.
3. 11/14 would prefer to be seen as a joint review in CF clinic and none wanted
to be see at the hospital diabetes clinic.
Following this, the diabetes specialist nurse attended clinic to provide support and
advice for both patients and staff.
Conclusion: Whilst a joint annual review with CF consultant and Diabetologist is
ideal, it is not always practical with small numbers. The presence of a Diabetes
nurse in CF clinic improved both the patients understanding and control of diabetes
and provided a more integrated service. Hospital visits were reduced whilst still
completing annual health checks. There continues to be input on a regular basis
with support from the Diabetologist. Practice will be reviewed in 2008 to look at
key areas for further development.
